Case File
efta-01865041DOJ Data Set 10OtherEFTA01865041
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01865041
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
James Henderson
From:
Jeffrey Epstein
Sent
Tue 5/24/2011 11:40:54 AM
Subject:
Re: Letter
unrelated is not strong enough, i need an extremely firm denial
On Tue, May 24, 2011 at 7:37 AM, James Henderson <[email protected]>
wrote:
Jeffrey
The letter is fine with the following amended Para I:
I wanted you to know with certainty, that many things said in the press about you that were
attributed to me were either fabricated from malicious headlines unrelated to anything I said,
or an outrageous exaggeration.
Let us know how you would like this — band written, email or typed and posted.
James
James Henderson
Managing Director
Direct li
Mobile:
Pelham Bell Pottinger
Pelham Bell Pottinger
6th
CN 7QD
Tel:
on.pelhanthellpottinger.co.uk
EFTA_R1_00267596
EFTA01865041
The award winning Bell Pottinger Group is part of Chime Communications plc
p prca
kt?",
Ea's Th.; HolmesReport
2011 DMA Cars ratio-en. we Vow
Bell Pon ins& Croup
V;e are committed to protecting the environment so please do not print this email unless you really need to.
Carbonisicutralk company
CONFIDENTIALITY NOTICE AND LEGAL LIABILITY WAIVER. Tho content of this email and any attachments aro CONFIDENTIAL and
may contain pnvileged information. If you are not the addressee it may be UNLAWFUL for you to read. copy. distribute. disclose or
otherwise use the information contained herein. The content of the message and or attachments may not reflect the view and opinions of
the onginating company or any party it is representing.
If you are NOT the intended recipient then please email back to itsuborailtchime plc uk
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00267597
EFTA01865042
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.